Brainstorm Cell Therapeutics | BCLI - Net Income

Stock Price
0.92
Daily Change
0.03 3.92%
Monthly
33.08%
Yearly
-33.94%
Q1 Forecast
0.82

Brainstorm Cell Therapeutics reported $-2.11M in Net Income for its fiscal quarter ending in September of 2025.





Net Income Change Date
Alterity Therapeutics Limited AUD -5.77M 2.26M Jun/2023
Biogen USD 466.5M 168.3M Sep/2025
Brainstorm Cell Therapeutics USD -2.11M 797K Sep/2025
Cipla INR 6.76B 6.75B Dec/2025
Clal Biotechnology ILS -6.17M 15.56M Dec/2022
Compugen USD 56.84M 63.82M Dec/2025
CSL USD 401M 96.5M Dec/2025
Cytokinetics USD -183.03M 123.15M Dec/2025
Gilead Sciences USD 2.18B 869M Dec/2025
Grifols EUR 114.37M 34.03M Dec/2025
Halozyme Therapeutics USD -141.59M 316.82M Dec/2025
Mesoblast USD -40.16M 14.05M Dec/2025